Abstract
Seipin is a protein located in the endoplasmic reticulum (ER) that plays a critical role in regulating adipogenesis and lipid droplet formation. While its deficiency is known to cause severe general lipodystrophy, its specific impact on perivascular adipose tissue (PVAT) and vascular homeostasis has not been extensively studied. This research investigates the role of Seipin in mediating the anticontractile effect of PVAT. Using a Seipin-knockout ($Seipin^{-/-}$ ) mouse model, researchers found that Seipin is highly expressed in PVAT but nearly absent in blood vessels. Deficiency led to a significant reduction in PVAT mass, impaired secretion of adipose-derived relaxing factors (ADRFs), and increased inflammation and ER stress. Functional assays demonstrated that $Seipin^{-/-}$ vessels exhibit impaired contractility and relaxation, highlighting Seipin's essential role in maintaining vascular health through functional PVAT.
Introduction: The Importance of Perivascular Fat
For decades, the fat surrounding blood vessels (PVAT) was viewed as mere structural support. Modern research has redefined PVAT as an active endocrine organ that secretes Adipose-Derived Relaxing Factors (ADRFs) to regulate vascular tone. The Seipin gene is vital for healthy fat cell development; mutations in humans cause Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), a condition marked by a near-total loss of body fat.
While the systemic metabolic consequences of Seipin deficiency, such as insulin resistance, are well-documented, its direct impact on the perivascular environment was previously unclear. This study explores whether the vascular dysfunction seen in lipodystrophy is a direct consequence of "sick" PVAT.
Methods
The researchers compared wild-type (WT) mice with $Seipin^{-/-}$ mice using a variety of high-resolution techniques:
- Wire Myography: Tiny rings of the aorta and mesenteric arteries were mounted to measure real-time contraction and relaxation in response to Phenylephrine (PHE) and Acetylcholine (Ach).
- Molecular Profiling: qPCR and Western blotting quantified the expression of genes and proteins related to inflammation, ER stress, and fibrosis.
- Advanced Imaging: Histological staining and Electron Microscopy (EM) visualized structural changes at the cellular level.
- Metabolic Testing: Glucose and insulin levels were monitored to confirm the systemic lipodystrophic phenotype.
Key Results
Profound Loss of Adipose Tissue
The $Seipin^{-/-}$ mice exhibited a dramatic reduction in fat mass across all measured depots. This included significant losses in subcutaneous and inguinal fat, as well as the critical aortic and mesenteric PVAT that surrounds major blood vessels.
Metabolic and Endocrine Dysfunction
Accompanying the loss of fat mass was a shift in metabolic markers. $Seipin^{-/-}$ mice showed significantly higher plasma insulin levels, indicating systemic insulin resistance, and a marked decrease in the beneficial adipokines leptin and adiponectin, which are essential for vascular health.
The "Sick Fat" Phenotype and Vascular Damage
Because Seipin is highly expressed in PVAT but barely detectable in the vessels themselves, the researchers concluded that vascular damage is a secondary effect of dysfunctional fat. In healthy mice, PVAT provides an "anticontractile" effect that protects the vessel. In $Seipin^{-/-}$ mice, this effect was lost. The remaining PVAT was characterized by:
- Inflammation: Massive infiltration of macrophages and upregulation of cytokines like TNF-α and IL-6.
- ER Stress: High expression of stress-related genes (CHOP, GRP78) in the PVAT.
- Structural Decay: Physical degradation of the underlying vessel, including deranged elastic fibers.
Discussion and Limitations
This study demonstrates for the first time that Seipin is critical for maintaining the functional integrity of PVAT and, by extension, vascular homeostasis. The findings suggest that the vascular complications associated with lipodystrophy are driven by the inflammatory and stressful environment of dysfunctional perivascular fat.
A primary limitation is the use of a global knockout model; a fat-specific knockout would be needed to definitively confirm that these effects are entirely PVAT-driven. Additionally, while vascular dysfunction was clear, the mice did not show overt hypertension, suggesting that compensatory mechanisms or environmental triggers (like a high-salt diet) might be necessary to manifest high blood pressure in this model.
Summary updated